Global and Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights, Forecast to 2027

Publisher Name :
Date: 13-Sep-2021
No. of pages: 136
Inquire Before Buying

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

Market Analysis and Insights: Global and Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market

This report focuses on global and Japan ICAD (Intracranial Atherosclerotic Disease) Pathology market.

In 2020, the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size was US$ 161 million and it is expected to reach US$ 288.6 million by the end of 2027, with a CAGR of 8.8% during 2021-2027. In Japan the ICAD (Intracranial Atherosclerotic Disease) Pathology market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Scope and Market Size

ICAD (Intracranial Atherosclerotic Disease) Pathology market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Stent

- PTA Balloon

Segment by Application

- Hospital

- Clinic

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Stryker

- Balt

- TERUMO

- MicroPort

- Acandis

Global and Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
1.2 Market by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Estimates and Forecasts
2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2027
2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2027
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology, Market Size by Region: 2016 VS 2021 VS 2027
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Historical Market Size by Region (2016-2021)
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Projections by Region (2022-2027)
2.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2022-2027)
2.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2022-2027)
3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Competitor Landscape by Players
3.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Sales
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2016-2021)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Revenue
3.2.1 Key ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Covered: Ranking by Revenue
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2021)
3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2016-2021)
3.2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2020
3.2.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturers
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Product Types
3.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
3.4.3 Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2016-2021)
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2016-2021)
4.1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2016-2021)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Type (2022-2027)
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2022-2027)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2022-2027)
4.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2016-2021)
5.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021)
5.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2016-2021)
5.1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2016-2021)
5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Application (2022-2027)
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2022-2027)
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2022-2027)
5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
6.1.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY Growth 2016-2027
6.1.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue YoY Growth 2016-2027
6.1.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in Global Market 2016-2027
6.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Players (International and Local Players)
6.2.1 Japan Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Sales (2016-2021)
6.2.2 Japan Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Revenue (2016-2021)
6.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Review by Type (2016-2021)
6.3.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021)
6.3.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2016-2021)
6.3.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2016-2021)
6.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2022-2027)
6.4.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2022-2027)
6.4.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Type (2022-2027)
6.5 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Review by Application (2016-2021)
6.5.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021)
6.5.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2016-2021)
6.5.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2016-2021)
6.6 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2022-2027)
6.6.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2022-2027)
6.6.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Application (2022-2027)
7 North America
7.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
7.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
7.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021)
7.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
8.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Region
8.2.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021)
8.2.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
9.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
9.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021)
9.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
10.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
10.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021)
10.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2016-2027
11.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
11.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021)
11.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Stryker
12.1.1 Stryker Corporation Information
12.1.2 Stryker Description and Business Overview
12.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.1.5 Stryker Recent Development
12.2 Balt
12.2.1 Balt Corporation Information
12.2.2 Balt Description and Business Overview
12.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.2.5 Balt Recent Development
12.3 TERUMO
12.3.1 TERUMO Corporation Information
12.3.2 TERUMO Description and Business Overview
12.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.3.5 TERUMO Recent Development
12.4 MicroPort
12.4.1 MicroPort Corporation Information
12.4.2 MicroPort Description and Business Overview
12.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.4.5 MicroPort Recent Development
12.5 Acandis
12.5.1 Acandis Corporation Information
12.5.2 Acandis Description and Business Overview
12.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.5.5 Acandis Recent Development
12.11 Stryker
12.11.1 Stryker Corporation Information
12.11.2 Stryker Description and Business Overview
12.11.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
12.11.5 Stryker Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
13.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
13.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
13.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Stent
Table 3. Major Manufacturers of PTA Balloon
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Application (2021-2027) & (Units)
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions (2016-2021) & (Units)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions (2016-2021)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2022-2027) & (Units)
Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Region (2022-2027)
Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2021) (Units)
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Revenue (US$ Million) in 2020
Table 16. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2016-2021)
Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2020)
Table 20. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2016-2021) (USD/Unit)
Table 21. ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
Table 23. Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) (Units)
Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2016-2021)
Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2016-2021) (US$ Million)
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2016-2021)
Table 29. ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2022-2027) & (Units)
Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Type (2022-2027)
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) (Units)
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2016-2021)
Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2016-2021) (US$ Million)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2016-2021)
Table 39. ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2022-2027) & (Units)
Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2022-2027)
Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) of Key Companies (2016-2021)
Table 46. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2016-2021)
Table 47. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Company (2016-2021)
Table 49. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2016-2021)
Table 50. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2016-2021)
Table 51. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2016-2021)
Table 53. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2022-2027)
Table 54. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2022-2027)
Table 55. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2022-2027)
Table 57. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2022-2027)
Table 58. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Application (2016-2021)
Table 59. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2016-2021)
Table 60. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2016-2021)
Table 62. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Application (2022-2027)
Table 63. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2022-2027)
Table 64. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2022-2027)
Table 66. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2022-2027)
Table 67. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 68. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 69. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021) & (Units)
Table 72. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021)
Table 75. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 76. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 77. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 79. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 80. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 84. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 87. Stryker Corporation Information
Table 88. Stryker Description and Business Overview
Table 89. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 91. Stryker Recent Development
Table 92. Balt Corporation Information
Table 93. Balt Description and Business Overview
Table 94. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Balt Product
Table 96. Balt Recent Development
Table 97. TERUMO Corporation Information
Table 98. TERUMO Description and Business Overview
Table 99. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. TERUMO Product
Table 101. TERUMO Recent Development
Table 102. MicroPort Corporation Information
Table 103. MicroPort Description and Business Overview
Table 104. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. MicroPort Product
Table 106. MicroPort Recent Development
Table 107. Acandis Corporation Information
Table 108. Acandis Description and Business Overview
Table 109. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Acandis Product
Table 111. Acandis Recent Development
Table 112. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
Table 113. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
Table 114. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
Table 115. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
Table 116. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 117. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 & 2027
Figure 3. Stent Product Picture
Figure 4. PTA Balloon Product Picture
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2016-2027 (US$ Million)
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2027 (Units)
Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021)
Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region in 2020
Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021)
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region in 2020
Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2020
Figure 20. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021)
Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020
Figure 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2016-2021)
Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type in 2020
Figure 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021)
Figure 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020
Figure 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2016-2021)
Figure 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application in 2020
Figure 29. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2016-2027 (Units)
Figure 30. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology in 2020
Figure 33. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2016-2021)
Figure 34. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2016-2021)
Figure 36. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2016-2021 (Units)
Figure 38. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2020
Figure 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2020
Figure 41. U.S. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2016-2021) (Units)
Figure 42. U.S. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2016-2021) (Units)
Figure 44. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2016-2021 (Units)
Figure 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2020
Figure 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2020
Figure 49. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2016-2021) (Units)
Figure 50. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2016-2021) (Units)
  • 2021-2027 Global and Regional Emergency Cervical Collar Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 24-Sep-2021        Price: US 3500 Onwards        Pages: 161
    The global Emergency Cervical Collar market was valued at 129.48 Million USD in 2020 and will grow with a CAGR of 7.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asi......
  • 2021-2027 Global and Regional Medical Ultra High Molecular Weight Polyethylene Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Medical Ultra High Molecular Weight Polyethylene market was valued at 40.36 Million USD in 2020 and will grow with a CAGR of 10.67% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(......
  • 2021-2027 Global and Regional Endoscopy Systems Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 152
    The global Endoscopy Systems market was valued at 7003.37 Million USD in 2020 and will grow with a CAGR of 4.79% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Euro......
  • 2021-2027 Global and Regional Condom Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 155
    The global Condom market was valued at 5284.22 Million USD in 2020 and will grow with a CAGR of 8.33% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South A......
  • 2021-2027 Global and Regional Postpartum Hemorrhage (PPH) Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 158
    The global Postpartum Hemorrhage (PPH) Devices market was valued at 570.75 Million USD in 2020 and will grow with a CAGR of 4.3% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America,......
  • 2021-2027 Global and Regional Pulse Oximeter Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Pulse Oximeter market was valued at 803.81 Million USD in 2020 and will grow with a CAGR of 4.88% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, ......
  • United States Punctal Plug Devices Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Punctal Plug Devices Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Punctal Plug Devices Market Segment Percentages, By Type, 2020 (%) - Temporary Punctal Plugs - Permanent Punctal Plugs United States Punctal Plug Devices Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Punctal Plug Devices Market Segment Percentages, By Application, 2020 (%) - Hospitals - Clini......
  • United States Pulse Tube Cryocoolers Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Pulse Tube Cryocoolers Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Pulse Tube Cryocoolers Market Segment Percentages, By Type, 2020 (%) - Single-Stage Pulse - Two-Stage Pulse United States Pulse Tube Cryocoolers Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Pulse Tube Cryocoolers Market Segment Percentages, By Application, 2020 (%) - Military - Electronics......
  • United States Pulse Oximeters Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Pulse Oximeters Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Pulse Oximeters Market Segment Percentages, By Type, 2020 (%) - Disposable Sensor - Reusable Sensor United States Pulse Oximeters Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Pulse Oximeters Market Segment Percentages, By Application, 2020 (%) - Hospital - Ambulatory Surgical Center - Home......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs